We are live on ! Find out more
LCM

Lynx1 Capital Management Portfolio holdings

AUM $633M
1-Year Est. Return 173.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+173.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$633M
AUM Growth
+$139M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
27
New
Increased
Reduced
Closed

Top Buys

1 +$71.8M
2 +$9.47M
3 +$5.48M
4
DNLI icon
Denali Therapeutics
DNLI
+$2.82M
5
TRDA icon
Entrada Therapeutics
TRDA
+$1.83M

Top Sells

1 +$21M
2 +$6.91M
3 +$2.1M
4
ARWR icon
Arrowhead Research
ARWR
+$800K
5
MPLT
MapLight Therapeutics
MPLT
+$237K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBIO
26
DELISTED
Generation Bio
GBIO
-25,000
MPLT
27
MapLight Therapeutics
MPLT
$1.32B
-13,477